• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

New-onset aortitis manifesting as relapsing giant cell arteritis successfully managed with tocilizumab monotherapy. A comment on: Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients. by Calderon-Goerc.

作者信息

Guarda Max, Araoz Philip A, Ghaffar Umar, Warrington Kenneth J, Koster Matthew J

机构信息

Department of Internal Medicine, Division of Rheumatology, Mayo Clinic, Rochester, MN, USA.

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

出版信息

Clin Exp Rheumatol. 2023 Apr;41(4):989-990. doi: 10.55563/clinexprheumatol/032qke. Epub 2023 Mar 20.

DOI:10.55563/clinexprheumatol/032qke
PMID:36995327
Abstract
摘要

相似文献

1
New-onset aortitis manifesting as relapsing giant cell arteritis successfully managed with tocilizumab monotherapy. A comment on: Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients. by Calderon-Goerc.新发主动脉炎表现为复发性巨细胞动脉炎，采用托珠单抗单药治疗成功控制。对《巨细胞动脉炎中托珠单抗治疗的优化。471例患者的多中心真实世界研究》的评论。作者：卡尔德隆 - 戈尔茨。
Clin Exp Rheumatol. 2023 Apr;41(4):989-990. doi: 10.55563/clinexprheumatol/032qke. Epub 2023 Mar 20.
2
Reply to: New-onset aortitis manifesting as relapsing giant cell arteritis successfully managed with tocilizumab monotherapy. by Guarda et al.回复：《新发主动脉炎表现为复发性巨细胞动脉炎，托珠单抗单药治疗成功》。作者：瓜尔达等人。
Clin Exp Rheumatol. 2023 Apr;41(4):991. doi: 10.55563/clinexprheumatol/ht170k. Epub 2023 Mar 21.
3
Active Aortitis and Dissection in Giant Cell Arteritis While on Tocilizumab Monotherapy.使用托珠单抗单药治疗时巨细胞动脉炎中的活动性主动脉炎和夹层形成
J Clin Rheumatol. 2021 Dec 1;27(8S):S832-S833. doi: 10.1097/RHU.0000000000001423.
4
Large vessel giant cell arteritis suggested by magnetic resonance imaging of the thigh: a potential mimicker of myositis, fasciitis and skeletal muscle vasculitis.
Rheumatology (Oxford). 2019 Dec 1;58(12):2211. doi: 10.1093/rheumatology/kez138.
5
Clinically isolated aortitis: imaging features and clinical outcomes: comparison with giant cell arteritis and giant cell aortitis.临床孤立性主动脉炎：影像学特征和临床结局：与巨细胞动脉炎和巨细胞性主动脉炎的比较。
Int J Cardiovasc Imaging. 2021 Apr;37(4):1433-1443. doi: 10.1007/s10554-020-02087-x. Epub 2020 Oct 30.
6
[Efficacy and tolerance of tocilizumab for corticosteroid sparing in giant cell arteritis and aortitis: Experience of Nimes University Hospital about eleven patients].托珠单抗在巨细胞动脉炎和主动脉炎中节省皮质类固醇的疗效及耐受性：尼姆大学医院关于11例患者的经验
Rev Med Interne. 2018 Feb;39(2):78-83. doi: 10.1016/j.revmed.2017.11.001. Epub 2017 Dec 6.
7
2018 Update of the EULAR recommendations for the management of large vessel vasculitis.2018 年版 EULAR 大血管血管炎管理建议更新。
Ann Rheum Dis. 2020 Jan;79(1):19-30. doi: 10.1136/annrheumdis-2019-215672. Epub 2019 Jul 3.
8
Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study.托珠单抗作为巨细胞动脉炎治疗前 3 个月糖皮质激素治疗的附加治疗：一项前瞻性研究。
Eur J Intern Med. 2018 Nov;57:96-104. doi: 10.1016/j.ejim.2018.06.008. Epub 2018 Jul 24.
9
Tocilizumab in Giant Cell Arteritis.托珠单抗治疗巨细胞动脉炎
Cardiol Rev. 2018 Nov/Dec;26(6):321-330. doi: 10.1097/CRD.0000000000000204.
10
Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.托珠单抗诱导和维持巨细胞动脉炎缓解的疗效：一项 2 期、随机、双盲、安慰剂对照试验。
Lancet. 2016 May 7;387(10031):1921-7. doi: 10.1016/S0140-6736(16)00560-2. Epub 2016 Mar 4.